Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Liesmann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer|April 15, 1981
Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancyJ Liesmann, R Belt, C Haas, et al.
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer Treatment Reports|March 1, 1981
Plasma levels and urinary excretion of methyl-GAG following iv infusion in manK C Marsh, J Liesmann, T F Patton, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer|April 15, 1981
Phase I evaluation of ICRF-187 (NSC-169780) in patients with advanced malignancyJ Liesmann, R Belt, C Haas, et al.
Cancer Treatment Reports|September 1, 1981
Phase I study on bruceantin administered on a weekly scheduleJ Liesmann, R J Belt, C D Haas, et al.
Cancer Treatment Reports|March 1, 1981
Plasma levels and urinary excretion of methyl-GAG following iv infusion in manK C Marsh, J Liesmann, T F Patton, et al.
Pageof 1